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Abstract
Injection drug users (IDUs) are considered as a high risk group to develop hepatitis C due to needle sharing. In this
study we have examined 200 injection drug users from various regions of the Khyber Pakhtunkhwa province for
the prevalence of active HCV infection and HCV genotypes by Immunochromatographic assays, RT-PCR and Type-
specific PCR. Our results indicated that 24% of the IDUs were actively infected with HCV while anti HCV was
detected among 31.5% cases. Prevalent HCV genotypes were HCV 2a, 3a, 4 and 1a. Majority of the IDUs were
married and had attained primary or middle school education. 95% of the IDUs had a previous history of needle
sharing. Our study indicates that the rate of active HCV infection among the IDUs is higher with comparatively
more prevalence of the rarely found HCV types in KPK. The predominant mode of HCV transmission turned out to
be needle sharing among the IDUs.
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Introduction
Hepatitis C is an infectious disease affecting the liver,
caused by the hepatitis C virus [1]. Infection with HCV
becomes persistent in > 70% of infected people and may
be associated with chronic hepatitis, cirrhosis and hepa-
tic cell carcinoma [2]. Approximately a quarter of a mil-
lion deaths per annum occur due to chronic liver
disease associated with HCV [3].
Hepatitis C continues to be a major disease burden on
the world. According to the WHO estimates, 3% of the
worldwide population is infected with the hepatitis C
virus [4]. The prevalence of chronic hepatitis C in the
Asia-pacific region is variable between 4% to 12% [5].
The overall observed modes of transmission in Paki-
stan are multiple use of needles/syringes (61.45%),
major/minor surgery/dental procedures (10.62%), blood
transfusion and blood products (4.26%), sharing razors
during shaving or circumcision by barbers (3.90%), pier-
cing instruments, nail clippers, tooth brushes, and in
less than 1% due to needle stick, from infected mother
to baby and sexual transmission [6,7].
A growing risk for the transmission of blood borne
diseases in Pakistan is related to injection drug use [8].
In Indonesia, China, Vietnam, Eastern Europe and Cen-
tral Asia outbreaks of HCV have been associated with
injection drug use [8-12]. Pakistan is considered to be
t h em a i nt r a f f i c k i n gr o u t ef o ro p i a t e sf r o mA f g h a n i s t a n
which produces the largest bulk of opium [13]. A recent
report by the United Nations estimated a country-wide
annual prevalence of 0.8% of opiate use in Pakistan [14].
Earlier studies have observed high HCV seroprevalence
among the Injection drug users in two cities of Pakistan
[15,16]. In Khyber Pakhtunkhwa province of Pakistan,
IDUs have never been investigated for active HCV infec-
tion or prevalent HCV genotypes. As seroprevalence of
anti-HCV does not tell us about whether the subjects
are actively infected and there was lack of prevalence
data on the active HCV infection or prevalent HCV gen-
otypes, therefore we undertook the study to analyze the
presence of HCV RNA and HCV genotypes prevalent
among the IDUs belonging to various regions of Khyber
Pakhtunkhwa province of Pakistan. The study also
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mission of HCV among the IDUs.
Materials and methods
Sampling
The study included IDUs from various parts of Khyber
Pakhtunkhwa including District Peshawar, District Mar-
dan and District Kohat. A proforma was filled by each
of the IDUs which contained information about previous
history of needle sharing, major or dental surgery, blood
transfusion, marital status and age etc. 5 ml of blood
was collected in each case in separate disposable syr-
inges and transported to the Institute of Biotechnology
and Genetic Engineering, Peshawar where serum separa-
tion was carried out. The study had been approved by
the board of study of IBGE. All experiments were per-
formed in accordance with the ethical standards men-
tioned in the declaration of Helsinki.
Immunochromatographic Tests (ICT)
Screening for HCV positive samples was carried out
with the help of Immuno-chromatographic tests (Accu-
rate, USA) followed by (Acon, USA). Samples positive
by ICT were furthered for next step evaluation.
RNA extraction and Qualitative PCR
HCV RNA was extracted from 100 μls e r u mb yu s i n g
Ana-gen RNA extraction kit (Ana-gen, USA) according
to the manufacturer’s instructions. Qualitative detection
of serum HCV RNA was performed by Reverse tran-
scription PCR as described previously [17].
HCV Genotyping
Genotyping of HCV was done according to the pre-
viously mentioned Type-specific PCR method [18].
All The PCR products were analyzed on 2% agarose
gel prepared in 0.5% TBE buffer, stained with ethedium
bromide (10 μg/ml) as florescent dye. Gels were photo-
graphed using Alpha quant (Alpha Innotech). 100-bp
DNA ladder (Gibco BRL) was used as DNA size marker.
Results
It is evident from the previous studies conducted in
Pakistan that Injection drug use is a predominant mode
of HCV transmission. We analyzed the blood samples of
200 IDUs belonging to various districts of the Khyber
P a k h t u n k h w ap r o v i n c e( T a b l e1 )f o rt h ep r e v a l e n c eo f
active HCV infection and HCV genotypes. Our results
indicated that out of the total 200 IDUs, 48 (24%) IDUs
had active HCV infection as detected by RT-PCR (Fig-
ure 1). Comparatively high percentage (31.5%) of the
IDUs had anti HCV in their blood (Table 2). Active
HCV was more prevalent in district Peshawar followed
by district Mardan and district Kohat (Table 2).
Prevalent HCV genotypes were 2a (35.71%), 3a (28.57%),
4 (14.29%) and 1a (7.14%) while the genotypes in 4
(14.29%) IDUs could not be determined by the assay
performed in this study (Table 3). Majority of the IDUs
were married, economically very poor with an income of
less than a dollar/day and had primary or middle school
level education (Table 1). Needle sharing was observed
in 95% cases.
Discussion
The burden of hepatitis C is increasing in Pakistan
partly, due to lack of public awareness and poor screen-
ing facilities in our health care units. HCV is a blood-
born pathogen and the investigated risk factors in Paki-
stan include major surgery, dental surgery, barbers,
occupational needle pricks and Injection drug use
[19-21]. Other studies from Pakistan have reported pre-
valence of anti-HCV antibodies among the IDUs from
various parts of the country [15,16]. In this study, we
investigated prevalence of active HCV infection among
the IDUs and found that 24% of them had HCV RNA
in their blood as detected by RT-PCR. The study
revealed that a considerably higher percentage (31.5%)
of the IDUs had anti-HCV antibodies in their sera
(Table 2). Detection of more anti-HCV cases in this
study could partly be attributed to the self limiting
Table 1 Demographics of IDUs
District No. of
IDUs
Male Female Married Education Economic
status
Peshawar 100 98 2 62
Kohat 60 60 - 30 Basic: 98% < 1$/day:
95%
Mardan 40 40 - 28 High: 2% Well off: 5%
Total 200 198 2 120
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Figure 1 Gel photograph of HCV PCR products: Lane 1 shows
100 bp DNA ladder, lane 2, and 3 are the positive samples for
active HCV infection showing 285 bp nested PCR product,
Lane 4 is positive HCV control while Lane 5 is negative control.
ur Rehman et al. Virology Journal 2011, 8:327
http://www.virologyj.com/content/8/1/327
Page 2 of 4nature of the disease or the limitations of the immuno-
chromatographic tests [22,23].
The distribution of HCV genotype 3 and 2 has been
reported to be worldwide including Pakistan [17]. All
the previous studies conducted in Pakistan have
employed type specific PCR for the detection of various
HCV genotypes. Earlier studies have reported that HCV
genotype 3a is the most abundant genotype among the
general population of Pakistan [17,24]. Our analysis
indicated that genotype 2a was the most prevalent fol-
l o w e db y3 aa m o n gt h eI D U si nK h y b e rP a k h t u n k h w a
province of Pakistan. HCV genotype 4 and 1a are only
rarely found in Pakistan and have earlier been reported
to be prevalent in Middle east, western countries, Aus-
tralia and the Americas [25] but this study indicated
that a considerable number of the IDUs were infected
with genotype 4 (Table 3). Former history of the IDUs
infected with genotype 4 and 1a revealed that a number
of them had a history of residing in the Gulf region or
Northerm America.
Injection drug use is uncommon among the female
population of Khyber Pakhtunkhwa where social con-
straints do not allow free mix ups with the males and
social interactions among the opposite sexes are limited.
In our study, we analyzed 2 females from the entire pro-
vince for HCV infection and both of them turned out to
be negative for anti-HCV.
Demographics of the IDUs (Table 1) indicated that
60% of the IDUs were married. Married IDUs pose a
greater risk of transmitting the disease to their spouses
or siblings. Education status of 98% of the IDUs was
basic (primary or middle school) and only 5% of the
IDUs were economically well off. Due to poor economic
status, increasing number of the IDUs have resorted to
beggary causing serious social problems. We also
noticed in this study that IDUs with a prolonged history
of Injection drug use were more infected with HCV as
compared to the novices. None of the IDUs had a his-
tory of major or dental surgery and only 5% had a his-
tory of blood transfusion. 95% of the IDUs had a
previous history of needle sharing although some of
them had quit with the practice. IDUs from Peshawar
district were relatively more aware of the risk of needle
sharing as compared to IDUs from other districts but
non of them were informed about hepatitis C. Our
study is in conformity with other studies conducted in
Pakistan which had reported increasing trend of Injec-
tion drug use [26]. According to the results of National
A s s e s s m e n tS t u d yo nD r u gA b u s eS i t u a t i o ni nP a k i s t a n ,
conducted in year 2000 it was estimated that about
60,000 drug addicts were using drugs through injections.
This study suggests that the government and non-gov-
ernmental organizations should launch projects to educate
people about hepatitis C and the transmission of HCV in
order to minimize the eminent threat of the spread of the
disease especially that of the rare genotypes which are
comparatively less responsive to Interferon-based thera-
pies. Policies regarding economic rehabilitation and psy-
chological counseling for the war-affected people should
help minimize the practice of Injection drug use.
Conclusion
The study concludes that 24% of the IDUs in KPK pro-
vince of Pakistan are actively infected with HCV. The
prevalent HCV genotypes are 2a, 3a, 4 and 1a. Lack of
awareness among the IDUs about needle sharing and
increasing trend of Injection drug use due to regional
socio-economic and geopolitical situation contributes a
great deal towards the spread of HCV.
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